Immunic
IMUX
IMUX
53 hedge funds and large institutions have $44.8M invested in Immunic in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.01% more ownership
Funds ownership: 0.67% → 0.68% (+0.01%)
4% less funds holding
Funds holding: 55 → 53 (-2)
Holders
53
Holding in Top 10
–
Calls
$100K
Puts
$16K
Top Buyers
| 1 | +$6M | |
| 2 | +$5.44M | |
| 3 | +$3.5M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$891K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$800K |
Top Sellers
| 1 | -$401K | |
| 2 | -$270K | |
| 3 | -$210K | |
| 4 |
Morgan Stanley
New York
|
-$152K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$66K |